Specific genetic alterations, such as mutations in DNA repair genes (BRCA1 (Breast Cancer 1), BRCA2 (Breast Cancer 2), ATM (Ataxia-Telangiectasia Mutated)), predict treatment outcomes and guide therapy-related decisions. Here, ATM is linked to breast carcinoma.